AHA 340B Letters to HHS and Drug Manufacturers

Following are letters from the American Hospital Association to HHS and selected drug manufacturers regarding recent 340B actions:

• HHS Secretary Alex M. Azar II – September 8, 2020
• AstraZeneca – August 21, 2020
• Eli Lilly – August 21, 2020
• Merck – August 21, 2020
• Novartis – August 21, 2020
• Sanofi – August 21, 2020